Parque Científico de Madrid
Campus de Cantoblanco
C/ Faraday, 7. 28049 Madrid
Diomune is a biotechnological company specialised in research and development of new immunological treatments which can be applied to human and animal health for infectious, inflammatory and autoimmune diseases.
Diomune´s technological innovation is based on the discovery of a family of immunomodulatory compounds which have an effect on receptors linked to innate immunity. The consequence of this interaction is that the development of inflammatory diseases can be prevented and that the immune response against pathogens or the effect of vaccines are boosted.
Diomune was founded by several researchers and professionals from the Severo Ochoa Molecular Biology Centre and prestigious pharmaceutical companies.
The Autonomous University of Madrid (UAM) has taken part in the company since it was created and it has received strong financial support from the Centre for the Development of Industrial Technology (CDTI).
Tags: Biotecnología, inmunología, infección, leishmaniosis canina, sepsis.